{"id":4825,"date":"2023-06-22T10:31:07","date_gmt":"2023-06-22T08:31:07","guid":{"rendered":"https:\/\/www.universalmedica.com\/?p=4825"},"modified":"2023-06-22T10:32:52","modified_gmt":"2023-06-22T08:32:52","slug":"simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors","status":"publish","type":"post","link":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/","title":{"rendered":"Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors"},"content":{"rendered":"<p>From 22 May 2023, clinical trial sponsors will be subject to new, simplified procedures for declaring the vigilance of the medicinal products tested, in accordance with the Jard\u00e9 law. The changes are as follows:<\/p>\n<p>Reporting of Suspected Unexpected Serious Adverse Reaction (SUSAR): from now on, these incidents must be transmitted exclusively electronically to the European Eudravigilance database. Simultaneous reporting to the French National Agency for the Safety of Medicines and Health Products (ANSM) is no longer required, except for clinical trials conducted in France on healthy volunteers. In the latter case, the procedures for reporting to the ANSM via declarationsusars@ansm.sante.fr and to Eudravigilance remain unchanged.<\/p>\n<p>Annual Safety Report (ASR) or Development Safety Update Report (DSUR) for clinical trials under the Jard\u00e9 Law: these reports must be submitted using a simplified form.<\/p>\n<p>The aim of these new procedures is to simplify the process for reporting clinical trial vigilance data.<\/p>\n<p>For more information on clinical trial vigilance, please consult the following link: <a href=\"https:\/\/ansm.sante.fr\/actualites\/vigilance-des-essais-cliniques-de-medicaments-des-modalites-de-declaration-simplifiees-pour-les-promoteurs\">Click<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>From 22 May 2023, clinical trial sponsors will be subject to new, simplified procedures for declaring the vigilance of the medicinal products tested, in accordance with the Jard\u00e9 law. The changes are as follows: Reporting of Suspected Unexpected Serious Adverse Reaction (SUSAR): from now on, these incidents must be transmitted exclusively electronically to the European [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4823,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[143,152,137],"tags":[],"class_list":["post-4825","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance","category-marketing-authorisation-2","category-pharmacovigilance-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors - Universal Medica<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors - Universal Medica\" \/>\n<meta property=\"og:description\" content=\"From 22 May 2023, clinical trial sponsors will be subject to new, simplified procedures for declaring the vigilance of the medicinal products tested, in accordance with the Jard\u00e9 law. The changes are as follows: Reporting of Suspected Unexpected Serious Adverse Reaction (SUSAR): from now on, these incidents must be transmitted exclusively electronically to the European [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/\" \/>\n<meta property=\"og:site_name\" content=\"Universal Medica\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-22T08:31:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-22T08:32:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2023\/06\/1_4.png\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gobi Nathan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gobi Nathan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/\"},\"author\":{\"name\":\"Gobi Nathan\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#\\\/schema\\\/person\\\/45029bc39741cfb27831e6380f0b218e\"},\"headline\":\"Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors\",\"datePublished\":\"2023-06-22T08:31:07+00:00\",\"dateModified\":\"2023-06-22T08:32:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/\"},\"wordCount\":176,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.universalmedica.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/1_4.png\",\"articleSection\":[\"Compliance\",\"Marketing authorisation\",\"Pharmacovigilance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/\",\"url\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/\",\"name\":\"Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors - Universal Medica\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.universalmedica.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/1_4.png\",\"datePublished\":\"2023-06-22T08:31:07+00:00\",\"dateModified\":\"2023-06-22T08:32:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#\\\/schema\\\/person\\\/45029bc39741cfb27831e6380f0b218e\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.universalmedica.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/1_4.png\",\"contentUrl\":\"https:\\\/\\\/www.universalmedica.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/1_4.png\",\"width\":500,\"height\":300},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/\",\"name\":\"Universal Medica\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.universalmedica.com\\\/fr\\\/#\\\/schema\\\/person\\\/45029bc39741cfb27831e6380f0b218e\",\"name\":\"Gobi Nathan\",\"url\":\"https:\\\/\\\/www.universalmedica.com\\\/en\\\/author\\\/gobi-nathanuniversalmedica-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors - Universal Medica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/","og_locale":"en_US","og_type":"article","og_title":"Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors - Universal Medica","og_description":"From 22 May 2023, clinical trial sponsors will be subject to new, simplified procedures for declaring the vigilance of the medicinal products tested, in accordance with the Jard\u00e9 law. The changes are as follows: Reporting of Suspected Unexpected Serious Adverse Reaction (SUSAR): from now on, these incidents must be transmitted exclusively electronically to the European [&hellip;]","og_url":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/","og_site_name":"Universal Medica","article_published_time":"2023-06-22T08:31:07+00:00","article_modified_time":"2023-06-22T08:32:52+00:00","og_image":[{"width":500,"height":300,"url":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2023\/06\/1_4.png","type":"image\/png"}],"author":"Gobi Nathan","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gobi Nathan","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/#article","isPartOf":{"@id":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/"},"author":{"name":"Gobi Nathan","@id":"https:\/\/www.universalmedica.com\/fr\/#\/schema\/person\/45029bc39741cfb27831e6380f0b218e"},"headline":"Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors","datePublished":"2023-06-22T08:31:07+00:00","dateModified":"2023-06-22T08:32:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/"},"wordCount":176,"commentCount":0,"image":{"@id":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2023\/06\/1_4.png","articleSection":["Compliance","Marketing authorisation","Pharmacovigilance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/","url":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/","name":"Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors - Universal Medica","isPartOf":{"@id":"https:\/\/www.universalmedica.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/#primaryimage"},"image":{"@id":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2023\/06\/1_4.png","datePublished":"2023-06-22T08:31:07+00:00","dateModified":"2023-06-22T08:32:52+00:00","author":{"@id":"https:\/\/www.universalmedica.com\/fr\/#\/schema\/person\/45029bc39741cfb27831e6380f0b218e"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.universalmedica.com\/en\/simplified-reporting-procedures-for-monitoring-the-safety-of-clinical-trials-simplified-procedures-for-sponsors\/#primaryimage","url":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2023\/06\/1_4.png","contentUrl":"https:\/\/www.universalmedica.com\/wp-content\/uploads\/2023\/06\/1_4.png","width":500,"height":300},{"@type":"WebSite","@id":"https:\/\/www.universalmedica.com\/fr\/#website","url":"https:\/\/www.universalmedica.com\/fr\/","name":"Universal Medica","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.universalmedica.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.universalmedica.com\/fr\/#\/schema\/person\/45029bc39741cfb27831e6380f0b218e","name":"Gobi Nathan","url":"https:\/\/www.universalmedica.com\/en\/author\/gobi-nathanuniversalmedica-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/posts\/4825","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/comments?post=4825"}],"version-history":[{"count":1,"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/posts\/4825\/revisions"}],"predecessor-version":[{"id":4826,"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/posts\/4825\/revisions\/4826"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/media\/4823"}],"wp:attachment":[{"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/media?parent=4825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/categories?post=4825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.universalmedica.com\/en\/wp-json\/wp\/v2\/tags?post=4825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}